-
Biedenkopf, N., Bukreyev, A., Chandran, K., Di Paola, N., Formenty, P. B. H., Griffiths, A., Hume, A. J., Muhlberger, E., Netesov, S. V., Palacios, G., Paweska, J. T., Smither, S., Takada, A., Wahl, V., Kuhn, J. H., 2023. Renaming of genera Ebolavirus and Marburgvirus to Orthoebolavirus and Orthomarburgvirus, respectively, and introduction of binomial species names within family Filoviridae. Arch. Virol. 168, 220.
-
Cao, Z., Liu, C., Peng, C., Ran, Y., Yao, Y., Xiao, G., Li, E., Chen, Z., Chuai, X., Chiu, S., 2023. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication. Virol. Sin. 38, 922-930.
-
Chung, H.J., Wang, S., Tang, J., 2007. Influence of heat transfer with tube methods on measured thermal inactivation parameters for Escherichia coli. J. Food Prot. 70, 851-859.
-
Feng, X. L., Li, B., Lin, H. F., Zheng, H. Y., Tian, R. R., Luo, R. H., Liu, M. Q., Jiang, R. D., Zheng, Y. T., Shi, Z. L., Bi, Y. H., Yang, X. L., 2021. Stability of SARS-CoV-2 on the surfaces of three meats in the setting that simulates the cold chain transportation. Virol. Sin. 36, 1069-1072.
-
Haddock, E., Feldmann, F., Feldmann, H., 2016. Effective chemical inactivation of Ebola virus. Emerg. Infect. Dis. 22, 1292-1294.
-
Mahanty, S., Bray, M., 2004. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect. Dis. 4, 487-498.
-
Mitchell, S.W., McCormick, J.B., 1984. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J. Clin. Microbiol. 20, 486-489.
-
National Health Commission of the People’s Republic of China, 2023. The List of Human Pathogenic Microorganisms. https://zwfw.nhc.gov.cn/kzx/tzgg/gzbxbywswsyhdsp_230/202311/t20231101_2629.html (accesssed 18 August 2023).
-
Negovetich, N.J., Webster, R.G., 2010. Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J. Virol. 84, 9367-9376.
-
Olejnik, J., Leon, J., Michelson, D., Chowdhary, K., Galvan-Pena, S., Benoist, C., Muhlberger, E., Hume, A. J., 2023. Establishment of an inactivation method for Ebola virus and SARS-CoV-2 suitable for downstream sequencing of low cell numbers. Pathogens 12, 342.
-
Pastorino, B., Touret, F., Gilles, M., Lamballerie, X., Charrel, R.N., 2020. Heat inactivation of different types of SARS-CoV-2 samples: What protocols for biosafety, molecular detection and serological diagnostics? Viruses 12, 735.
-
Smither, S.J., Weller, S.A., Phelps, A., Eastaugh, L., Ngugi, S., O'Brien, L.M., Jackie Steward, J., Lonsdale, S.G., Lever, M.S., 2015. Buffer AVL alone does not inactivate Ebola virus in a representative clinical sample type. J. Clin. Microbiol. 53, 3148-3154.
-
Tuladhar, E., Bouwknegt, M., Zwietering, M.H., Koopmans, M., Duizer, E., 2012. Thermal stability of structurally different viruses with proven or potential relevance to food safety. J. Appl. Microbiol. 112, 1050-1057.